DISCINESIAS INDUZIDAS POR LEVODOPA: TRANSIÇÃO DE HIPOCINESIA PARA HIPERCINESIA NA DOENÇA DE PARKINSON
Jonas Nogueira Dias Júnior, Leticia de Freitas, João Nathã Siqueira Silva, Júlia Rizzo Marin, Milene Gonçalves Zoppé, Thúlio Vivas Ferraz Scalco Costa · 2026
Read DISCINESIAS INDUZIDAS POR LEVODOPA: TRANSIÇÃO DE HIPOCINESIA PARA HIPERCINESIA NA DOENÇA DE PARKINSON by Jonas Nogueira Dias Júnior, Leticia de Freitas, João Nathã Siqueira Silva, Júlia Rizzo Marin, Milene Gonçalves Zoppé, Thúlio Vivas Ferraz Scalco Costa (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/openalex-w7213742912.txt.
Description
Jonas Nogueira Dias Júnior leads a review on levodopa-induced dyskinesia in Parkinson's disease. Levodopa remains the strongest drug for motor symptoms, yet long use can bring movements patients cannot control. Their 2026 review searched PubMed for 2017 to 2025 and kept eleven papers.
Dyskinesias were tied to steady loss of dopamine neurons and to pulsed dopamine dosing. Changes in how synapses adapt, and in serotonin, glutamate, and swelling pathways, also play a part. In practice, patients move from too little motion toward too much, with swings and growing loss of daily function. Grasping that shift, the authors argue, is key to keeping treatment benefit while limiting one of its worst costs.
Catalog record
| CREATOR | Jonas Nogueira Dias Júnior, Leticia de Freitas, João Nathã Siqueira Silva, Júlia Rizzo Marin, Milene Gonçalves Zoppé, Thúlio Vivas Ferraz Scalco Costa |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 31 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | OpenAlex / Revista Ibero-Americana de Humanidades, Ciências e Educação |